BETA

6 Amendments of Michèle RIVASI related to 2020/2170(DEC)

Amendment 1 #
Draft opinion
Paragraph 1
1. Recalls that the European Chemicals Agency ('ECHA') is the driving force among regulatory authorities in implementing the Union's chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness; notes that it provides information on chemicals, helps companies comply with legislation and advances the safe use of chemicals; underlines that Regulation (EC) No 1907/20061a (REACH Regulation) specifies that this should be done in a way that ensures that animal testing is only ever a last resort and that the use of non- animal methods is promoted; __________________ 1aRegulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).
2020/12/17
Committee: ENVI
Amendment 3 #
Draft opinion
Paragraph 3 a (new)
3a. Calls for ECHA, as one of the Union agencies responsible for assessing regulated products, to receive sufficient funding to carry out its tasks;
2020/12/17
Committee: ENVI
Amendment 6 #
Draft opinion
Paragraph 6 a (new)
6a. Regrets the lack of resources in the ECHA budget dedicated specifically to ensuring knowledge and promotion of non-animal testing methods; reiterates its call to provide resources for staff within ECHA exclusively dedicated to animal protection and the promotion of non- animal methods across all ECHA activities1a; __________________ 1aEuropean Parliament resolution of 10 July 2020 on the Chemicals Strategy for Sustainability, P9 TA(2020)0201
2020/12/17
Committee: ENVI
Amendment 9 #
Draft opinion
Paragraph 8 a (new)
8a. Encourages ECHA to pursue its efforts to perform its REACH dossier evaluation checks and to make the process more effective; recalls that dossiers evaluation checks on over 2 000 dossiers covering 700 substances revealed that 70 % of the dossiers were not compliant with the legal information requirements of REACH or did not contain sufficient information to ensure a safe use for Union citizens and the environment;
2020/12/17
Committee: ENVI
Amendment 10 #
Draft opinion
Paragraph 8 b (new)
8b. Asks ECHA to improve the transparency and the user-friendliness of its database, and the interface between evaluation and follow-up risk management, including, for example, a short note on the ECHA’s registered substances in the database with regard to the compliance and evaluation status of the dossiers adding outcome of substance evaluation (further risk management needed or not), stating explicitly if the dossier was found non-compliant and on what ground and adding the outcome of Board of Appeal decisions as well as the follow up delivered or intended by ECHA;
2020/12/17
Committee: ENVI
Amendment 11 #
Draft opinion
Paragraph 8 c (new)
8c. Asks ECHA to develop guidance on the minimum information requirements needed to justify granting derogations to restrictions and to ensure that no derogation is accepted when registration dossiers are not compliant or updated;
2020/12/17
Committee: ENVI